Log in

Relevant bibliographies by topics / Tolérance des lymphocytes T / Journal articles

To see the other types of publications on this topic, follow the link: Tolérance des lymphocytes T.

Journal articles on the topic 'Tolérance des lymphocytes T'

Author: Grafiati

Published: 18 May 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Tolérance des lymphocytes T.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Bonnefoy, Nathalie, Daniel Olive, and Bernard Vanhove. "Les futures générations d’anticorps modulateurs des points de contrôle de la réponse immunitaire." médecine/sciences 35, no. 12 (December 2019): 966–74. http://dx.doi.org/10.1051/medsci/2019193.

Full text

Abstract:

Les points de contrôle du système immunitaire sont des systèmes moléculaires qui complètent les processus déclenchés par la reconnaissance antigénique en contrôlant l’inhibition ou l’activation des lymphocytes et des cellules myéloïdes, notamment celle des lymphocytes T régulateurs (Treg), permettant ainsi de combiner réponses immunes et maintien de la tolérance au soi. En cancérologie, l’inhibition de points de contrôle inhibiteurs vise à amplifier les réponses immunitaires existantes dirigées contre les tumeurs. Parmi ces points de contrôle inhibiteurs, dont des antagonistes sont en utilisation clinique, se trouvent CTLA-4 (cytolytic T-lymphocyte-associated antigen 4 ou CD152), PD-1 (programmed cell death 1, ou CD279), PD-L1 (programmed cell death-ligand 1, ou CD274), LAG-3 (Lymphocyte-activation gene 3, ou CD223), TIM3 (T-cell immunoglobulin and mucin-domain containing-3), TIGIT (T cell immunoreceptor with Ig and ITIM domains), VISTA (V-domain Ig suppressor of T cell activation), ou B7/H3 (ou CD276). La stimulation de points de contrôle activateurs tels que les molécules de co-activation CD28, CD137 (aussi appelé 4-1BB), OX40 [aussi appelé tumor necrosis factor receptor superfamily, member 4 (TNFRSF4)], GITR (Glucocorticoid-induced tumor necrosis factor receptor family-related protein) ou CD40, est également testée en cancérologie, le plus souvent en combinaison avec un antagoniste de point de contrôle inhibiteur. Dans les maladies auto-immunes et inflammatoires, des antagonistes de points de contrôle activateurs (CD28, CD40) et des agonistes de points de contrôle inhibiteurs (LAG-3) sont également à l’essai. Dans cette revue, nous mettons l’accent sur certains modulateurs de points de contrôle pour lesquels le mécanisme d’action a été particulièrement étudié. Cette description ne pouvant être exhaustive, nous avons regroupé dans le Tableau I l’ensemble des anticorps monoclonaux (AcM) ou protéines recombinantes en usage clinique à notre connaissance, modulant l’action d’un point de contrôle du système immunitaire.

APA, Harvard, Vancouver, ISO, and other styles

2

Hequet, Olivier, Marc Vocanson, Aurélie Guironnet-paquet, Audrey Nosbaum, and Jean-François Nicolas. "Les lymphocytes T CD8+ suppresseurs jouent un rôle majeur dans la tolérance immunitaire induite par la photochimiothérapie extracorporelle." Annales de Dermatologie et de Vénéréologie 143, no. 12 (December 2016): S426. http://dx.doi.org/10.1016/j.annder.2016.09.066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ochoa, Juan B., and Valeriya Makarenkova. "T lymphocytes." Critical Care Medicine 33, Suppl (December 2005): S510—S513. http://dx.doi.org/10.1097/01.ccm.0000186788.71460.53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Fabbri, M. "T lymphocytes." International Journal of Biochemistry & Cell Biology 35, no. 7 (July 2003): 1004–8. http://dx.doi.org/10.1016/s1357-2725(03)00037-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lotteau, V. "La période de tolérance néonatale existe-t-elle ?" médecine/sciences 12, no. 8-9 (1996): 983. http://dx.doi.org/10.4267/10608/859.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Robijn, R. J., T. Logtenberg, L. J. J. M. Wiegman, G. P. Van Berge Henegouwen, R. W. Houwen, and J. C. Koningsberger. "Intestinal T Lymphocytes." Scandinavian Journal of Gastroenterology 30, sup212 (January 1995): 23–33. http://dx.doi.org/10.3109/00365529509090298.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Degos, L. "Les lymphocytes T." médecine/sciences 3, no. 4 (1987): 229. http://dx.doi.org/10.4267/10608/3665.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;. "Cytotoxic T lymphocytes." Reactions Weekly &NA;, no. 1085 (January 2006): 12–13. http://dx.doi.org/10.2165/00128415-200610850-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

MARTIN, STEPHEN, ED CANTIN, and BARRY T. ROUSE. "Cytotoxic T Lymphocytes." Annals of the New York Academy of Sciences 532, no. 1 Cytotoxic T C (August 1988): 257–72. http://dx.doi.org/10.1111/j.1749-6632.1988.tb36344.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Langelot, M., K. Botturi-Cavaillès, D. Lair, F. Wessel, P. Germaud, A. Pipet, and A. Magnan. "Lymphocytes T régulateurs." Revue Française d'Allergologie 50, no. 3 (April 2010): 98–101. http://dx.doi.org/10.1016/j.reval.2010.02.015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Aubin, F., and Ph Saas. "Lymphocytes T régulateurs." Annales de Dermatologie et de Vénéréologie 134, no. 2 (February 2007): 167–72. http://dx.doi.org/10.1016/s0151-9638(07)91612-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Ashton-Rickardt, P. G., and J. T. Opferman. "Memory T lymphocytes." Cellular and Molecular Life Sciences (CMLS) 56, no. 1-2 (October 1, 1999): 69–77. http://dx.doi.org/10.1007/s000180050007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Guichard, Pierre. "L'Andalousie a-t-elle été un paradis de tolérance ?" Les Grands Dossiers des Sciences Humaines N° Hors-série, HS5 (February 1, 2017): 60–61. http://dx.doi.org/10.3917/gdsh.hs5.0060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

BAGOT, M., M. NIKOLOVA, F. SCHIRM-CHABANETTE, J. WECHSLER, L. BOUMSELL, and A. BENSUSSAN. "Crosstalk between Tumor T Lymphocytes and Reactive T Lymphocytes in Cutaneous T Cell Lymphomas." Annals of the New York Academy of Sciences 941, no. 1 (January 25, 2006): 31–38. http://dx.doi.org/10.1111/j.1749-6632.2001.tb03708.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hayward, Anthony R. "T-Lymphocytes: An Update." Pediatric Annals 16, no. 5 (May 1, 1987): 391–94. http://dx.doi.org/10.3928/0090-4481-19870501-06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Smyth, Mark J., Michael H. Kershaw, and Joseph A. Trapani. "XENOSPECIFIC CYTOTOXIC T LYMPHOCYTES." Transplantation 63, no. 8 (April 1997): 1171–78. http://dx.doi.org/10.1097/00007890-199704270-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bouladoux, Nicolas, Timothy W. Hand, Shruti Naik, and Yasmine Belkaid. "Microbiote et lymphocytes T." médecine/sciences 29, no. 4 (April 2013): 349–52. http://dx.doi.org/10.1051/medsci/2013294005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Rouers, Angeline, Raphaël Jeger-Madiot, Arnaud Moris, and Stéphanie Graff-Dubois. "Lymphocytes T folliculaireshelperet VIH." médecine/sciences 33, no. 10 (October 2017): 878–86. http://dx.doi.org/10.1051/medsci/20173310020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hamid, Qutayba. "T Lymphocytes in Asthma." Allergy & Clinical Immunology International - Journal of the World Allergy Organization 11, no. 5 (1999): 0192–94. http://dx.doi.org/10.1027/0838-1925.11.5.192.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Ward, Stephen G., Kevin Bacon, and John Westwick. "Chemokines and T Lymphocytes." Immunity 9, no. 1 (July 1998): 1–11. http://dx.doi.org/10.1016/s1074-7613(00)80583-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Nur Çakmak, Fatma, Metin Erol, Pynar Ergül, and Altan Yalçyner. "T lymphocytes and vitamins." Journal of Pediatrics 135, no. 4 (October 1999): 531. http://dx.doi.org/10.1016/s0022-3476(99)70185-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Daugherty, Alan, and Debra L. Rateri. "T Lymphocytes in Atherosclerosis." Circulation Research 90, no. 10 (May 31, 2002): 1039–40. http://dx.doi.org/10.1161/01.res.0000021397.28936.f9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Vallejo, Abbe N., Eduardo Davila, Cornelia M. Weyand, and Jörg J. Goronzy. "Biology of T lymphocytes." Rheumatic Disease Clinics of North America 30, no. 1 (February 2004): 135–57. http://dx.doi.org/10.1016/s0889-857x(03)00114-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Prens, Errol, Reno Debets, and Joost Hegmans. "T lymphocytes in psoriasis." Clinics in Dermatology 13, no. 2 (March 1995): 115–29. http://dx.doi.org/10.1016/0738-081x(95)93818-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Adibzadeh, M., E. Mariani, C. Bartoloni, I. Beckman, G. Ligthart, E. Remarque, S. Shall, et al. "Lifespans of T lymphocytes." Mechanisms of Ageing and Development 91, no. 2 (October 1996): 145–54. http://dx.doi.org/10.1016/0047-6374(96)01783-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Nanno, Masanobu, Yutaka Kanamori, Hisashi Saito, Mariko Kawaguchi-Miyashita, Shin-ichiro Shimada, and Hiromichi Ishikawa. "Intestinal Intraepithelial T Lymphocytes." Immunologic Research 18, no. 1 (August 1998): 41–53. http://dx.doi.org/10.1007/bf02786512.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kabelitz, Dieter. "Human γδ T Lymphocytes." International Archives of Allergy and Immunology 102, no. 1 (1993): 1–9. http://dx.doi.org/10.1159/000236544.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Globerson, Amiela. "T Lymphocytes and Aging." International Archives of Allergy and Immunology 107, no. 4 (1995): 491–97. http://dx.doi.org/10.1159/000237091.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

KABELITZ, D., W. R. HERZOG, B. ZANKER, and H. WAGNER. "Human Cytotoxic T Lymphocytes." Scandinavian Journal of Immunology 22, no. 3 (September 1985): 329–35. http://dx.doi.org/10.1111/j.1365-3083.1985.tb01888.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

BERGSTROM, S. E., D. HAUZENBERGER, and K. G. SUNDQVIST. "T Lymphocytes Degrade Fibronectin." Scandinavian Journal of Immunology 33, no. 4 (April 1991): 453–59. http://dx.doi.org/10.1111/j.1365-3083.1991.tb01794.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Guy-Grand, Delphine, and Pierre Vassalli. "Gut intraepithelial T lymphocytes." Current Opinion in Immunology 5, no. 2 (January 1993): 247–52. http://dx.doi.org/10.1016/0952-7915(93)90012-h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kononova, T. E., O. I. Urazova, V. V. Novitskii, and P. A. Zakharova. "CYTOKINE-SECRETORY ACTIVITY OF T-LYMPHOCYTES-HELPERS 17 AND T-LYMPHOCYTES-HELPERS 1 / T-LYMPHOCYTES-HELPERS 17 IN PULMONARY TUBERCULOSIS." Siberian Medical Review, no. 6 (2017): 57–62. http://dx.doi.org/10.20333/2500136-2017-6-57-62.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dietl, Johannes, Hans-Peter Horny, Peter Ruck, Klaus Marzusch, Edwin Kaiserling, Henrik Griesser, and Dieter Kabelitz. "Intradecidual T lymphocytes lack T-cell receptors." American Journal of Obstetrics and Gynecology 164, no. 2 (February 1991): 702. http://dx.doi.org/10.1016/s0002-9378(11)80055-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira, and Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus." Blood 66, no. 1 (July 1, 1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.120.

Full text

Abstract:

Abstract We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

APA, Harvard, Vancouver, ISO, and other styles

35

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira, and Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus." Blood 66, no. 1 (July 1, 1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.bloodjournal661120.

Full text

Abstract:

We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

APA, Harvard, Vancouver, ISO, and other styles

36

Vianna-Jorge, Rosane, and Guilherme Suarez-Kurtz. "Potassium Channels in T Lymphocytes." BioDrugs 18, no. 5 (2004): 329–41. http://dx.doi.org/10.2165/00063030-200418050-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Guse, Andreas H. "Ca2+ Signaling in T-Lymphocytes." Critical Reviews™ in Immunology 18, no. 5 (1998): 419–48. http://dx.doi.org/10.1615/critrevimmunol.v18.i5.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Jandrić-Kočić, Marijana. "Recirculation of naive T lymphocytes." Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 27, no. 86 (2022): 25–48. http://dx.doi.org/10.5937/mgiszm2286025j.

Full text

Abstract:

After development in the thymus, naive T lymphocytes come into circulation and continuously recirculate between the blood and peripheral lymphoid organs for activation and transformation into effector cells. The movement of naive T lymphocytes represents an ordered sequence controlled by the expression of specific of specific proteins (selectin, integrin and chemokine) that includes the recruitment of circulating lymphocytes on the luminal surface of the blood vessel, transendothelial transition and migration within the extravascular compartment of peripheral lymphoid organs. The question of the movement of naive T lymphocytes in and out of non-lymphoid organs in physiological conditions has not been fully resolved. There is an opinion that naive T lymphocytes under physiological conditions routinely access almost all non-lymphoid organs for the purpose of immunosurveillance and/or tolerance induction. Non-lymphoid organs burdened by chronic inflammation and tumor processes may possess a significant number of naive T lymphocytes. Organized lymphoid tissue causally contributes to the persistence of certain autoimmune diseases. Recruitment in tumor tissue and subsequent antitumor immune response correspond with a positive prognosis.

APA, Harvard, Vancouver, ISO, and other styles

39

Bockenstedt, Linda K., Mark A. Goldsmith, Gary A. Koretzky, and Arthur Weiss. "The Activation of T Lymphocytes." Rheumatic Disease Clinics of North America 13, no. 3 (December 1987): 411–30. http://dx.doi.org/10.1016/s0889-857x(21)00926-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Krensky, Alan M., and Carol Clayberger. "MHC-Unrestricted cytolytic T lymphocytes." Survey of Immunologic Research 4, no. 4 (December 1985): 297–302. http://dx.doi.org/10.1007/bf02918737.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Rowe-Pirra, William. "Comment s’épuisent les lymphocytes T." Pour la Science N° 530 – décembre, no. 12 (November 29, 2021): 12. http://dx.doi.org/10.3917/pls.530.0012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Arokiaraj, M. C., and E. Menesson. "Rose treatment on T lymphocytes." Atherosclerosis 331 (August 2021): e81. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.238.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Kay, A. B., and S. R. Durham. "T-lymphocytes, allergy and asthma." Clinical Experimental Allergy 21, s1 (May 1991): 17–21. http://dx.doi.org/10.1111/j.1365-2222.1991.tb01700.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Sheibak, V. M., and A. Y. Pauliukavets. "Biochemical heterogeneity of T-lymphocytes." Vestnik of Vitebsk State Medical University 17, no. 6 (November 29, 2018): 7–17. http://dx.doi.org/10.22263/2312-4156.2018.6.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Martinez, Olivia M. "Immunobiology of CD30+ T Lymphocytes." Graft 4, no. 3 (April 2001): 180–87. http://dx.doi.org/10.1177/152216280100400302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Dotti, Gianpietro. "T Lymphocytes Are Not Immune." Molecular Therapy 21, no. 6 (June 2013): 1114–15. http://dx.doi.org/10.1038/mt.2013.102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

VON BOEHMER, HARALD, HORST BLUETHMANN, UWE STAERZ, MICHAEL STEINMETZ, and PAWEL KISIELOW. "Developmental Biology of T Lymphocytes." Annals of the New York Academy of Sciences 546, no. 1 Molecular Bas (December 1988): 104–8. http://dx.doi.org/10.1111/j.1749-6632.1988.tb21624.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

van Oosterhout, A. J. M. "Regulatory T-lymphocytes in asthma." European Respiratory Journal 26, no. 5 (November 1, 2005): 918–32. http://dx.doi.org/10.1183/09031936.05.00011205.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

BERETTA, LAURA. "TRANSLATIONAL CONTROL IN T LYMPHOCYTES." International Reviews of Immunology 23, no. 3-4 (January 2004): 347–63. http://dx.doi.org/10.1080/08830180490452549.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Vié, H., and B. Clémenceau. "Transfert adoptif de lymphocytes T." Transfusion Clinique et Biologique 24, no. 3 (September 2017): 256–62. http://dx.doi.org/10.1016/j.tracli.2017.05.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!